Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colonic Neoplasms 5Pancreatic Neoplasms 3Inflammatory Bowel Diseases 3Diverticulitis 3Carcinoma, Hepatocellular 3Stomach Neoplasms 1Psychological Well-Being 1Postoperative Complications 1Motor Activity 1Lung Neoplasms 1Liver Neoplasms 1Hypotension 1Esophageal Neoplasms 1Duodenal Neoplasms 1Colorectal Neoplasms 1Agnosia 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Tea × Gastrointestinal × Clear all
NCT06621472 2026-03-18

Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery

Cairo University

Phase NA Recruiting
90 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01837381 2019-09-03

Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC)

Chinese University of Hong Kong

Phase NA Completed
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00467974 2015-01-26

Transarterial Ethanol Ablation (TEA) Versus Transcatheter Arterial Chemoembolisation (TACE) for Hepatocellular Carcinoma

Chinese University of Hong Kong

Phase 3 Completed
98 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡